nouvelles
les langues
Live Cam
contact
empreinte
Ulm
Français
fr
Deutsch
de
English
en
nouvelles
les langues
Live Cam
contact
empreinte
Français
fr
Deutsch
de
English
en
EKM WS18 Introduction à la médecine clinique
GTE Développement historique de la médecine
Medizin
Button
Afficher davantage
Robert Koch Institut
Rote Liste
Pub Med
Dolosys
cardiologie
FEB
18
Wearable blood pressure sensors for cardiovascular monitoring and machine learning algorithms for blood pressure estimation
By:
Seongwook Min
on
FEB
18
Nature Reviews Cardiology, Published online: 18 February 2025; doi:10.1038/s41569-025-01127-0In this Review, Lee and colleagues describe the biosignal sensing principles of wearable blood pressure sensors and discuss blood pressure estimation methods, including the use of machine learning algorithms.
En savoir plus >>
FEB
12
Clinical implications of perioperative and periprocedural myocardial infarction
By:
Konstantin A. Krychtiuk
on
FEB
12
Nature Reviews Cardiology, Published online: 12 February 2025; doi:10.1038/s41569-025-01137-yDiffering definitions and questionable prognostic significance have caused confusion and controversy around the applicability of the current definitions of periprocedural and perioperative myocardial infarction in clinical practice. In this Clinical Outlook, we review the definitions and the clinical and prognostic relevance of the various entities and provide implications for clinical practice.
En savoir plus >>
FEB
11
Author Correction: Traction force microscopy of cardiomyocytes
By:
Maia Lyall
on
FEB
11
Nature Reviews Cardiology, Published online: 11 February 2025; doi:10.1038/s41569-025-01139-wAuthor Correction: Traction force microscopy of cardiomyocytes
En savoir plus >>
FEB
10
Remuscularizing the failing heart in primates
By:
Gregory B. Lim
on
FEB
10
Nature Reviews Cardiology, Published online: 10 February 2025; doi:10.1038/s41569-025-01136-zTissue engineered heart muscle implanted on to the epicardium can structurally and functionally remuscularize the failing hearts of rhesus macaques, with no major adverse effects; a clinical trial of this approach is now underway in patients with heart failure.
En savoir plus >>
FEB
07
Tracing the roots of cardiac fibrosis: role of endothelial-to-mesenchymal transition
By:
Elizabeth Figueroa-Juárez
on
FEB
07
Nature Reviews Cardiology, Published online: 07 February 2025; doi:10.1038/s41569-025-01134-1Elizabeth Figueroa-Juárez describes the study that demonstrated that fibroblasts derived from endothelial cells through endothelial-to-mesenchymal transition contribute to cardiac fibrosis.
En savoir plus >>
FEB
07
Vagal circuits in the heart and gut can regulate cardiometabolism and stress responses
By:
Karina Huynh
on
FEB
07
Nature Reviews Cardiology, Published online: 07 February 2025; doi:10.1038/s41569-025-01133-2A new study shows that activation of vagal sensory neurons expressing the oxytocin receptor in the cardiovascular and gastrointestinal tissues of mice mediates cardiometabolic changes resembling those from a hibernation-like, hypometabolic state.
En savoir plus >>
FEB
07
Novel pharmacological approaches to lowering blood pressure and managing hypertension
By:
Matthew Sayer
on
FEB
07
Nature Reviews Cardiology, Published online: 07 February 2025; doi:10.1038/s41569-025-01131-4Hypertension is the leading cause of death globally but has low rates of diagnosis and treatment. In this Review, Dhaun and colleagues discuss the reasons for poor control of hypertension, such as therapeutic inertia and poor patient adherence, as well as novel pharmacological approaches to blood pressure lowering.
En savoir plus >>
FEB
03
Predictive cardio-omics: translating single-cell multiomics into tools for personalized medicine
By:
Kami Pekayvaz
on
FEB
03
Nature Reviews Cardiology, Published online: 03 February 2025; doi:10.1038/s41569-025-01132-3In this Clinical Outlook, we describe available multiomic studies in cardiovascular medicine, discuss the advantages and potential of multiomic techniques for clinical translation in cardiology, and highlight three promising aspects: the generation of unprecedented cellular atlases, the identification of composite diagnostic and prognostic biomarkers derived from integrative multiomic signatures, and the isolation of potential therapeutic targets from unbiased comprehensive datasets and analyses.
En savoir plus >>
Weitere Beiträge
Oncologie clinique
FEB
18
Outcome correlates of approved CD19-targeted CAR T cells for large B cell lymphoma
By:
Tamara J. Bock
on
FEB
18
Nature Reviews Clinical Oncology, Published online: 18 February 2025; doi:10.1038/s41571-025-00992-5CD19-targeted CAR T cells have transformed the management of patients with relapsed and/or refractory large B cell lymphoma, and these therapies are increasingly being administered as earlier-line therapies. Nonetheless, the prognosis of these patients is often difficult to predict, with various prospective and real-world studies suggesting that a wide range of factors are associated with treatment outcomes. In this Review, the authors summarize these various associations as well as their implications for patient selection and management.
En savoir plus >>
FEB
13
Less-frequent surveillance is noninferior to annual mammography
By:
Peter Sidaway
on
FEB
13
Nature Reviews Clinical Oncology, Published online: 13 February 2025; doi:10.1038/s41571-025-01001-5Less-frequent surveillance is noninferior to annual mammography
En savoir plus >>
FEB
11
Artificial intelligence in digital pathology — time for a reality check
By:
Arpit Aggarwal
on
FEB
11
Nature Reviews Clinical Oncology, Published online: 11 February 2025; doi:10.1038/s41571-025-00991-6The authors of this Perspective evaluate the developments in the use of artificial intelligence (AI) in digital pathology for oncology applications between 2019 and 2024, addressing technological innovations, regulatory trends, implementation and financial implications. Importantly, they explore the current landscape of clinical deployment, highlighting future opportunities for the integration of AI into clinical oncology routine practice.
En savoir plus >>
FEB
10
Intermediate-affinity CD19-directed CAR T cell product obecabtagene autoleucel demonstrates favourable safety and efficacy in R/R B-ALL
By:
Rawan G. Faramand
on
FEB
10
Nature Reviews Clinical Oncology, Published online: 10 February 2025; doi:10.1038/s41571-025-00993-4Recent data from the FELIX trial evaluating obecabtagene autoleucel in patients with relapsed and/or refractory B acute lymphoblastic leukaemia (R/R B-ALL) suggest that this novel intermediate-affinity CD19-directed chimeric antigen receptor (CAR) T cell therapy is associated with a reduced incidence of severe immune-mediated toxicities compared with other commercially available CAR T cell products. The increasing number of therapies available for B-ALL makes treatment selection and sequencing of therapies increasingly challenging.
En savoir plus >>
FEB
10
AI accurately identifies targetable alterations in lung cancer histological images
By:
Hortense Le
on
FEB
10
Nature Reviews Clinical Oncology, Published online: 10 February 2025; doi:10.1038/s41571-025-00999-yDeepGEM, an artificial intelligence (AI)-based model, accurately predicts the presence of key genomic alterations in histological slides prepared from samples obtained from patients with lung cancer. This approach provides a cost-effective alternative to genomic testing, generates spatial mutation maps and might support personalized treatment strategies. Validated in diverse datasets, DeepGEM highlights the potential of AI to transform precision oncology and improve global healthcare equity.
En savoir plus >>
FEB
07
Cadonilimab is efficacious in HER2-negative advanced-stage G/GEJ adenocarcinomas
By:
Diana Romero
on
FEB
07
Nature Reviews Clinical Oncology, Published online: 07 February 2025; doi:10.1038/s41571-025-00998-zCadonilimab is efficacious in HER2-negative advanced-stage G/GEJ adenocarcinomas
En savoir plus >>
FEB
06
Transanal TME noninferior to the laparoscopic approach
By:
Peter Sidaway
on
FEB
06
Nature Reviews Clinical Oncology, Published online: 06 February 2025; doi:10.1038/s41571-025-00997-0Transanal TME noninferior to the laparoscopic approach
En savoir plus >>
FEB
06
International approvals of cilta-cel: a lens on CAR T cell regulation
By:
Chenghao Ge
on
FEB
06
Nature Reviews Clinical Oncology, Published online: 06 February 2025; doi:10.1038/s41571-025-00996-1The BCMA-targeted chimeric antigen receptor (CAR) T cell therapy ciltacabtagene autoleucel (cilta-cel) has demonstrated exceptional efficacy in studies conducted worldwide, which has resulted in regulatory approvals in >40 countries. Herein, we examine the regulatory pathways that led to its approval in different regions, focus on challenges in clinical development and regulatory submission, and provide insight into strategies for advancing innovative cell therapies.
En savoir plus >>
Weitere Beiträge
endocrinologie
FEB
18
The study that pioneered islet isolation techniques
By:
Rula Bany Bakar
on
FEB
18
Nature Reviews Endocrinology, Published online: 18 February 2025; doi:10.1038/s41574-025-01093-0The study that pioneered islet isolation techniques
En savoir plus >>
FEB
11
Tryptophan metabolism, exercise and depression
By:
Brandon A. Yates
on
FEB
11
Nature Reviews Endocrinology, Published online: 11 February 2025; doi:10.1038/s41574-025-01090-3Tryptophan metabolism, exercise and depression
En savoir plus >>
FEB
11
Recent advances in treatments for congenital adrenal hyperplasia
By:
Henrik Falhammar
on
FEB
11
Nature Reviews Endocrinology, Published online: 11 February 2025; doi:10.1038/s41574-025-01089-wThe first CRFR1 antagonist (crinecerfont) to be used for the treatment of congenital adrenal hyperplasia recently received FDA approval. This Clinical Outlook discusses the latest phase III studies in children and adults, as well as how crinecerfont — in combination with glucocorticoid replacement — might change clinical practice and affect long-term co-morbidities.
En savoir plus >>
FEB
04
Hypoparathyroidism: diagnosis, management and emerging therapies
By:
Sarah Khan
on
FEB
04
Nature Reviews Endocrinology, Published online: 04 February 2025; doi:10.1038/s41574-024-01075-8Hypoparathyroidism is a rare condition characterized by inadequate levels of parathyroid hormone (PTH) or resistance to PTH, leading to a wide range of health complications and reduced quality of life. This Review provides an update on the current understanding of hypoparathyroidism, its clinical management, and novel and emerging therapies.
En savoir plus >>
JAN
29
Exercise exacerbates cardiac damage from high-fat, high-calorie feeding in mice
By:
Olivia Tysoe
on
JAN
29
Nature Reviews Endocrinology, Published online: 29 January 2025; doi:10.1038/s41574-025-01087-yExercise exacerbates cardiac damage from high-fat, high-calorie feeding in mice
En savoir plus >>
JAN
16
The effects of type 1 and type 2 diabetes mellitus on bone health in chronic kidney disease
By:
Jasna Aleksova
on
JAN
16
Nature Reviews Endocrinology, Published online: 16 January 2025; doi:10.1038/s41574-024-01083-8Fracture is an under-recognized complication of diabetes mellitus; bone strength and function are also compromised in chronic kidney disease, a well-known complication of diabetes mellitus. Superimposing the bone-related effects of both these disorders increases the risk of fracture, as outlined in this Review.
En savoir plus >>
JAN
15
Exploring the functions of the myokine feimin
By:
Claire Greenhill
on
JAN
15
Nature Reviews Endocrinology, Published online: 15 January 2025; doi:10.1038/s41574-025-01086-zExploring the functions of the myokine feimin
En savoir plus >>
JAN
09
Management, biomarkers and prognosis in people developing endocrinopathies associated with immune checkpoint inhibitors
By:
Shintaro Iwama
on
JAN
09
Nature Reviews Endocrinology, Published online: 09 January 2025; doi:10.1038/s41574-024-01077-6Endocrine immune-related adverse events can occur in response to immune checkpoint inhibitors and can be severe. However, in some cancer types, if treated appropriately with hormone-replacement therapies, certain endocrine immune-related adverse events have been reported to be associated with favourable prognoses, as outlined in this Review.
En savoir plus >>
Weitere Beiträge
hépatologie
FEB
17
Influence of biological sex in inflammatory bowel diseases
By:
Diane M. Tshikudi
on
FEB
17
Nature Reviews Gastroenterology & Hepatology, Published online: 17 February 2025; doi:10.1038/s41575-025-01038-yBiological sex has a vital role in the pathogenesis of inflammatory bowel disease (IBD). This Review examines sex in IBD pathophysiology and clinical manifestation and provides a frame for improving clinical and preclinical IBD studies by considering sex an essential factor.
En savoir plus >>
FEB
17
Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment
By:
Christopher D. Byrne
on
FEB
17
Nature Reviews Gastroenterology & Hepatology, Published online: 17 February 2025; doi:10.1038/s41575-025-01045-zThis Review discusses the link between metabolic dysfunction-associated steatotic liver disease (MASLD) — a heterogeneous health condition — and hepatic and extrahepatic disease manifestations and provides a comprehensive platform for personalized, holistic management for patients with MASLD.
En savoir plus >>
FEB
12
Neuroimmune interactions influence pancreatic glucagon secretion in fasting mice
By:
Jordan Hindson
on
FEB
12
Nature Reviews Gastroenterology & Hepatology, Published online: 12 February 2025; doi:10.1038/s41575-025-01049-9Neuroimmune interactions influence pancreatic glucagon secretion in fasting mice
En savoir plus >>
FEB
10
Author Correction: Understanding the therapeutic toolkit for inflammatory bowel disease
By:
Sophie Vieujean
on
FEB
10
Nature Reviews Gastroenterology & Hepatology, Published online: 10 February 2025; doi:10.1038/s41575-025-01047-xAuthor Correction: Understanding the therapeutic toolkit for inflammatory bowel disease
En savoir plus >>
FEB
07
Bridging the gap between science and survival
By:
Ahsen Ustaoglu
on
FEB
07
Nature Reviews Gastroenterology & Hepatology, Published online: 07 February 2025; doi:10.1038/s41575-025-01044-0A scientist’s personal journey through breast cancer underscores the urgency for greater empathy in research and healthcare, a patient-centred approach to data dissemination, and more comprehensive, streamlined support for early-career researchers navigating health crises.
En savoir plus >>
FEB
05
New potent HBV replication inhibitors for the management of chronic hepatitis B are needed
By:
Timothy M. Block
on
FEB
05
Nature Reviews Gastroenterology & Hepatology, Published online: 05 February 2025; doi:10.1038/s41575-025-01037-zWith several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular, are not necessary. Here, we make the counter-argument that additional direct-acting antiviral drugs that can potently suppress hepatitis B virus replication, ideally via distinct mechanisms, are still needed and can provide additional therapeutic benefits.
En savoir plus >>
FEB
04
Is precision microbiome medicine just around the corner?
By:
Silvia Turroni
on
FEB
04
Nature Reviews Gastroenterology & Hepatology, Published online: 04 February 2025; doi:10.1038/s41575-025-01040-4A study in Nature Medicine developed a new clinical test based on a gut metagenome-derived multispecies biomarker panel for the diagnosis of inflammatory bowel disease, which outperformed faecal calprotectin. Shortly after, a study in Cell identified a health-relevant network-based core microbiome that could substantially advance precision microbiome medicine.
En savoir plus >>
FEB
04
MASLD as a non-communicable disease
By:
Silvia Sookoian
on
FEB
04
Nature Reviews Gastroenterology & Hepatology, Published online: 04 February 2025; doi:10.1038/s41575-025-01039-xNon-communicable diseases represent the primary cause of mortality and morbidity globally, accounting for 74% of all deaths and more than three-quarters of years lived with disability. Here, we argue that metabolic dysfunction-associated steatotic liver disease should be considered a non-communicable disease.
En savoir plus >>
Weitere Beiträge
néphrologie
FEB
11
Advances and challenges in kidney fibrosis therapeutics
By:
Lilia Abbad
on
FEB
11
Nature Reviews Nephrology, Published online: 11 February 2025; doi:10.1038/s41581-025-00934-5Fibrosis has a key role in the progression of kidney disease and kidney failure. Here, the authors examine current options for targeting pro-fibrotic pathways, including the anti-fibrotic potential of nephroprotective drugs, as well as technological advances that might improve kidney fibrosis outcomes.
En savoir plus >>
FEB
04
Publisher Correction: Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia
By:
Dieter Haffner
on
FEB
04
Nature Reviews Nephrology, Published online: 04 February 2025; doi:10.1038/s41581-025-00939-0Publisher Correction: Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia
En savoir plus >>
FEB
03
Artificial intelligence approaches to enable early detection of CKD
By:
Navdeep Tangri
on
FEB
03
Nature Reviews Nephrology, Published online: 03 February 2025; doi:10.1038/s41581-025-00933-6The late diagnosis of chronic kidney disease (CKD) is a global problem that limits the opportunity to initiate disease-modifying therapies. Artificial intelligence approaches using imaging or laboratory-based models can facilitate the early detection and risk stratification of CKD and thereby enable optimal treatment to reduce the burden of the disease.
En savoir plus >>
JAN
30
The kidney harbours a microbiota that may influence lithogenesis
By:
Ellen F. Carney
on
JAN
30
Nature Reviews Nephrology, Published online: 30 January 2025; doi:10.1038/s41581-025-00937-2The kidney harbours a microbiota that may influence lithogenesis
En savoir plus >>
JAN
30
Risk-directed management of chronic kidney disease
By:
Matthew F. Blum
on
JAN
30
Nature Reviews Nephrology, Published online: 30 January 2025; doi:10.1038/s41581-025-00931-8Several risk tools can accurately predict individual baseline risks of adverse events in people with chronic kidney disease. Here, the authors examine methods of assessing risk and discuss risk-directed patient management, whereby risk is aligned with care delivery to maximize the benefit of available therapeutic strategies.
En savoir plus >>
JAN
29
Loss of B cell protection in uraemic kidney disease
By:
Monica Wang
on
JAN
29
Nature Reviews Nephrology, Published online: 29 January 2025; doi:10.1038/s41581-025-00936-3Loss of B cell protection in uraemic kidney disease
En savoir plus >>
JAN
28
Insights into the burden of CKDu
By:
Susan J. Allison
on
JAN
28
Nature Reviews Nephrology, Published online: 28 January 2025; doi:10.1038/s41581-025-00935-4Insights into the burden of CKDu
En savoir plus >>
JAN
22
Born too soon: lifelong kidney risks and the importance of early intervention
By:
Enrico Vidal
on
JAN
22
Nature Reviews Nephrology, Published online: 22 January 2025; doi:10.1038/s41581-025-00932-7Premature birth and low birth weight disrupt kidney development substantially, which leads to an increased risk of acute kidney injury, chronic kidney disease and hypertension. Broader awareness of these risks, implementation of preventive strategies and optimization of neonatal care are key to safeguarding kidney health and ensuring better long-term outcomes.
En savoir plus >>
Weitere Beiträge
neurologie
FEB
17
CNS drug delivery improves chemotherapy
By:
Ian Fyfe
on
FEB
17
Nature Reviews Neurology, Published online: 17 February 2025; doi:10.1038/s41582-025-01070-1CNS drug delivery improves chemotherapy
En savoir plus >>
FEB
17
Neurogenesis altered by disease and stimulation
By:
Ian Fyfe
on
FEB
17
Nature Reviews Neurology, Published online: 17 February 2025; doi:10.1038/s41582-025-01068-9Neurogenesis altered by disease and stimulation
En savoir plus >>
FEB
17
Parkinson disease pathology can originate in the kidney
By:
Lisa Kiani
on
FEB
17
Nature Reviews Neurology, Published online: 17 February 2025; doi:10.1038/s41582-025-01066-xNew research suggests that pathological α-synuclein in Parkinson disease can propagate from kidney to brain.
En savoir plus >>
FEB
17
Degeneration decades before disease onset
By:
Ian Fyfe
on
FEB
17
Nature Reviews Neurology, Published online: 17 February 2025; doi:10.1038/s41582-025-01069-8Degeneration decades before disease onset
En savoir plus >>
FEB
17
Identification of neurons involved in schizophrenia
By:
Ian Fyfe
on
FEB
17
Nature Reviews Neurology, Published online: 17 February 2025; doi:10.1038/s41582-025-01067-wIdentification of neurons involved in schizophrenia
En savoir plus >>
FEB
10
Nothing about us, without us — establishing a patient and public involvement and engagement group
By:
Rachel Horne
on
FEB
10
Nature Reviews Neurology, Published online: 10 February 2025; doi:10.1038/s41582-025-01063-0Implementation of patient and public involvement and engagement (PPIE) to enable patients and carers to feel included and equal to healthcare professionals is challenging to do well. Here, leaders of a PPIE group share their lived experience and highlight the importance of addressing the needs of all participants to enable true partnership.
En savoir plus >>
FEB
10
Moving towards meaningful patient and public engagement
By:
Ruth Dobson
on
FEB
10
Nature Reviews Neurology, Published online: 10 February 2025; doi:10.1038/s41582-025-01061-2Patient and public involvement and engagement is increasingly mandated in funding applications, yet often remain tokenistic and transitory. Working with patient and public contributors requires investment, thought, care and time. We discuss approaches that aim to increase agency for coresearchers, with the goal of strengthening public confidence and trust in research.
En savoir plus >>
FEB
04
The impact of rare genetic variants on Alzheimer disease
By:
Lara De Deyn
on
FEB
04
Nature Reviews Neurology, Published online: 04 February 2025; doi:10.1038/s41582-025-01062-1In this Review, the authors summarize the genetic and epidemiological characteristics of rare variants associated with Alzheimer disease so far, and explore the insights that these variants have provided into the pathogenic mechanisms of the disease.
En savoir plus >>
Weitere Beiträge
rhumatologie
FEB
14
Connecting the structure and function of cartilage using spatial ‘-omics’
By:
Indira Prasadam
on
FEB
14
Nature Reviews Rheumatology, Published online: 14 February 2025; doi:10.1038/s41584-025-01225-wAdvances in spatial ‘-omics’, such as transcriptomics and proteomics, have provided vital insights into cartilage microenvironments, revealing cellular diversity, zonal organization and links between cartilage structure and function. Analysing cartilage using spatial ‘-omics’ could deepen the understanding of diseases such as osteoarthritis and guide the development of targeted, disease-modifying therapies.
En savoir plus >>
FEB
14
An international perspective on the future of systemic sclerosis research
By:
David J. Abraham
on
FEB
14
Nature Reviews Rheumatology, Published online: 14 February 2025; doi:10.1038/s41584-024-01217-2The diagnosis, treatment and management of systemic sclerosis (SSc) remains challenging, owing to the complexity of this disease. In this Perspective, an international group of experts discuss the future of SSc research and how the advent of innovative technologies will advance research into and understanding of SSc.
En savoir plus >>
FEB
10
A direct link between SARS-CoV-2 and bone loss
By:
Sarah Onuora
on
FEB
10
Nature Reviews Rheumatology, Published online: 10 February 2025; doi:10.1038/s41584-025-01224-xResearch demonstrates that the SARS-CoV-2 protein ORF8 drives osteoclastogenesis, establishing a direct link between viral infection and bone loss.
En savoir plus >>
FEB
07
Antigen-driven T cell responses in rheumatic diseases: insights from T cell receptor repertoire studies
By:
Jose Garrido-Mesa
on
FEB
07
Nature Reviews Rheumatology, Published online: 07 February 2025; doi:10.1038/s41584-025-01218-9Garrido-Mesa and Brown review findings from TCR profiling studies in rheumatic diseases and discuss how improved study design might help elicit information about autoreactive T cell clones and their contribution to disease pathogenesis.
En savoir plus >>
FEB
06
Genome-wide mutagenesis reported in systemic sclerosis
By:
Carol M. Artlett
on
FEB
06
Nature Reviews Rheumatology, Published online: 06 February 2025; doi:10.1038/s41584-025-01219-8The mechanisms that drive the diverse disease manifestations and increased cancer risk associated with systemic sclerosis are unclear. Investigating the genomic alterations observed in patients with systemic sclerosis could contribute towards untangling this complex disease.
En savoir plus >>
FEB
05
Occupational dust and chemical exposures and the development of autoimmune rheumatic diseases
By:
Mandana Nikpour
on
FEB
05
Nature Reviews Rheumatology, Published online: 05 February 2025; doi:10.1038/s41584-024-01216-3This Review discusses the current evidence for the association between occupational exposures, particularly silica dust and solvents, and the risk of developing systemic autoimmune rheumatic diseases. The authors emphasize the importance of considering occupational history in the rheumatology clinic.
En savoir plus >>
JAN
31
T cells in Sjögren disease
By:
Holly Webster
on
JAN
31
Nature Reviews Rheumatology, Published online: 31 January 2025; doi:10.1038/s41584-025-01220-1A mouse model that reflects Sjögren disease in humans provides insights into the role of regulatory T cells and type 1 helper T cells in disease pathogenesis.
En savoir plus >>
JAN
28
Virome associations in autoimmunity and COVID-19
By:
Maria Papatriantafyllou
on
JAN
28
Nature Reviews Rheumatology, Published online: 28 January 2025; doi:10.1038/s41584-025-01221-0The detection of anellovirus or eHHV-6B genomes in the blood virome seems to correlate with the risk or severity of rheumatic diseases and COVID-19.
En savoir plus >>
Weitere Beiträge
urologie
FEB
18
Addressing diversity barriers in prostate cancer clinical trials for equitable healthcare outcomes
By:
Peter Lang
on
FEB
18
Nature Reviews Urology, Published online: 18 February 2025; doi:10.1038/s41585-025-01008-8Prostate cancer is the most common cancer in men, yet disparities persist in screening, diagnosis and treatment among populations with low socioeconomic status. Minority groups face barriers to clinical trial inclusion including limited awareness and financial challenges. Promoting diversity in clinical trials is crucial for inclusivity, improving treatment efficacy and achieving equitable health outcomes in prostate cancer care.
En savoir plus >>
FEB
18
Treatment strategies in human papillomavirus-related advanced penile cancer
By:
Mattia Longoni
on
FEB
18
Nature Reviews Urology, Published online: 18 February 2025; doi:10.1038/s41585-025-00994-zIn this Review, the authors describe the intricate interplay of chemo-radio-immuno-sensitization in advanced penile squamous cell carcinoma with human papillomavirus (HPV) co-infections. By drawing parallels with other HPV-driven tumours, they provide arguments for the development of effective therapeutic strategies tailored to the unique characteristics of advanced penile squamous cell carcinoma with HPV co-infection.
En savoir plus >>
FEB
17
Bringing bi-paternal offspring a step closer
By:
Louise Lloyd
on
FEB
17
Nature Reviews Urology, Published online: 17 February 2025; doi:10.1038/s41585-025-01012-yBringing bi-paternal offspring a step closer
En savoir plus >>
FEB
12
An exploratory study of new predictive biomarkers of castration resistance
By:
Annette Fenner
on
FEB
12
Nature Reviews Urology, Published online: 12 February 2025; doi:10.1038/s41585-025-01007-9An exploratory study of new predictive biomarkers of castration resistance
En savoir plus >>
FEB
11
GDF15 blockade can reduce immunotherapy resistance in urothelial cancer
By:
Maria Chiara Masone
on
FEB
11
Nature Reviews Urology, Published online: 11 February 2025; doi:10.1038/s41585-025-01005-xGDF15 blockade can reduce immunotherapy resistance in urothelial cancer
En savoir plus >>
FEB
10
The key to humanitarian urology: do not import the surgeon, create trained local surgical teams
By:
J. Rubio-Briones
on
FEB
10
Nature Reviews Urology, Published online: 10 February 2025; doi:10.1038/s41585-025-01003-zHumanitarian surgical missions provide substantial benefits to the involved surgeon and to the recipient communities. These missions should be planned and executed with the final aim to train local teams to implement innovative or standard surgical techniques.
En savoir plus >>
FEB
10
Breaking barriers in urology — surgical accessibility for urologists with paraplegia
By:
Juan Carlos Castaño Botero
on
FEB
10
Nature Reviews Urology, Published online: 10 February 2025; doi:10.1038/s41585-025-01004-yThe path to become a urological surgeon is full of obstacles. Historically, individuals with a physical disability have faced substantial barriers in their training and practice. However, the development of the right environment can ensure that these challenges do not hinder the progress of surgeons.
En savoir plus >>
JAN
31
Impact and importance of a new men’s health strategy in England
By:
John Chisholm
on
JAN
31
Nature Reviews Urology, Published online: 31 January 2025; doi:10.1038/s41585-025-01001-1The Government’s commitment to a Men’s Health Strategy in England, announced by Wes Streeting, the Secretary of State for Health and Social Care, on 28 November 2024, is a welcome development. The implementation of a strategy will hopefully lead to improved access to services and health outcomes for men and boys.
En savoir plus >>
Weitere Beiträge
Partager
Tweet
Partager
Courrier
La version française de ce site est principalement traduite automatiquement par "google translate". En cas de difficultés linguistiques, n'hésitez pas à me contacter.
Share by: